Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Celgene
Nanfang Hospital, Southern Medical University
European Organisation for Research and Treatment of Cancer - EORTC